Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models.

Kalkan KT, Yalcin B, Yildiz HT, Katirci E, Koseoglu E, Bolat D, Yay A

Open source

DOI
10.1186/s12906-025-05013-7
Published
2025 Jul 14
Container
BMC complementary medicine and therapies
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12906-025-05013-7,
  title = {Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models.},
  author = {Kalkan KT and Yalcin B and Yildiz HT and Katirci E and Koseoglu E and Bolat D and Yay A},
  year = {2025},
  journal = {BMC complementary medicine and therapies},
  doi = {10.1186/s12906-025-05013-7},
  url = {https://doi.org/10.1186/s12906-025-05013-7}
}

RIS

TY  - JOUR
TI  - Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models.
AU  - Kalkan KT
AU  - Yalcin B
AU  - Yildiz HT
AU  - Katirci E
AU  - Koseoglu E
AU  - Bolat D
AU  - Yay A
PY  - 2025
JO  - BMC complementary medicine and therapies
DO  - 10.1186/s12906-025-05013-7
UR  - https://doi.org/10.1186/s12906-025-05013-7
ER  - 

APA

KT, K., B, Y., HT, Y., E, K., E, K., D, B., & A, Y. (2025). Royal jelly alleviates gemcitabine-induced ovarian toxicity: an investigation on rat models.. BMC complementary medicine and therapies. https://doi.org/10.1186/s12906-025-05013-7

Source records